88 related articles for article (PubMed ID: 16319505)
41. Subtypes of family history and conduct disorder: effects on P300 during the stroop test.
Bauer LO; Hesselbrock VM
Neuropsychopharmacology; 1999 Jul; 21(1):51-62. PubMed ID: 10379519
[TBL] [Abstract][Full Text] [Related]
42. A family history of substance dependence obscures the group differences in brain function associated with HIV-1 and ART.
Bauer LO
Drug Alcohol Depend; 2013 Jan; 127(1-3):45-52. PubMed ID: 22749564
[TBL] [Abstract][Full Text] [Related]
43. Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior.
Brooner RK; Bigelow GE; Strain E; Schmidt CW
Drug Alcohol Depend; 1990 Aug; 26(1):39-44. PubMed ID: 2209414
[TBL] [Abstract][Full Text] [Related]
44. P300 decrements in teenagers with conduct problems: implications for substance abuse risk and brain development.
Bauer LO; Hesselbrock VM
Biol Psychiatry; 1999 Jul; 46(2):263-72. PubMed ID: 10418702
[TBL] [Abstract][Full Text] [Related]
45. The effects of HIV on P300 are moderated by familial risk for substance dependence: implications for a theory of brain reserve.
Bauer LO
Drug Alcohol Depend; 2008 Apr; 94(1-3):92-100. PubMed ID: 18065165
[TBL] [Abstract][Full Text] [Related]
46. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions.
Messina N; Farabee D; Rawson R
J Consult Clin Psychol; 2003 Apr; 71(2):320-9. PubMed ID: 12699026
[TBL] [Abstract][Full Text] [Related]
47. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida.
Surratt HL; Kurtz SP; Cicero TJ; O'Grady C; Levi-Minzi MA
Am J Public Health; 2013 Jun; 103(6):1026-8. PubMed ID: 23597362
[TBL] [Abstract][Full Text] [Related]
48. Kidney disease in HIV-positive children.
McCulloch MI; Ray PE
Semin Nephrol; 2008 Nov; 28(6):585-94. PubMed ID: 19013330
[TBL] [Abstract][Full Text] [Related]
49. Frontal brain dysfunction in alcoholism with and without antisocial personality disorder.
Oscar-Berman M; Valmas MM; Sawyer KS; Kirkley SM; Gansler DA; Merritt D; Couture A
Neuropsychiatr Dis Treat; 2009; 5():309-26. PubMed ID: 19557141
[TBL] [Abstract][Full Text] [Related]
50. Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.
Hocqueloux L; Saez-Cirion A; Rouzioux C
JAMA Intern Med; 2013 Mar; 173(6):475-6. PubMed ID: 23529554
[No Abstract] [Full Text] [Related]
51. For human immunodeficiency virus disease, more treatment seems to be better: comment on "Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion".
Katz MH
Arch Intern Med; 2012 Sep; 172(16):1256. PubMed ID: 22824829
[No Abstract] [Full Text] [Related]
52. Relationship of prospective memory to neuropsychological function and antiretroviral adherence.
Contardo C; Black AC; Beauvais J; Dieckhaus K; Rosen MI
Arch Clin Neuropsychol; 2009 Sep; 24(6):547-54. PubMed ID: 19648150
[TBL] [Abstract][Full Text] [Related]
53. Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply.
Porter K; Lodi S; Meyer L
JAMA Intern Med; 2013 Mar; 173(6):476-7. PubMed ID: 23529555
[No Abstract] [Full Text] [Related]
54. Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy.
Chao LL; Cardenas VA; Meyerhoff DJ; Rothlind JC; Flenniken DL; Lindgren JA; Weiner MW
Neuroreport; 2003 Nov; 14(16):2111-5. PubMed ID: 14600507
[TBL] [Abstract][Full Text] [Related]
55. Emotional deficit as a neuropsychopathological disturbance in HIV infection.
Bungener C; Jouvent R
J Int Neuropsychol Soc; 2001 Sep; 7(6):775-7. PubMed ID: 11575599
[No Abstract] [Full Text] [Related]
56. Diffuse Non-Genital Cutaneous Warts.
Singh RK
Am J Trop Med Hyg; 2021 Oct; 106(2):378-379. PubMed ID: 34695802
[No Abstract] [Full Text] [Related]
57. Obesity, smoking, and frontal brain dysfunction.
Bauer L; Dick D; Bierut L; Bucholz K; Edenberg H; Kuperman S; Kramer J; Nurnberger J; O'Connor S; Rice J; Rohrbaugh J; Schuckit M; Tischfield J; Porjesz B; Hesselbrock V
Am J Addict; 2010; 19(5):391-400. PubMed ID: 20716301
[TBL] [Abstract][Full Text] [Related]
58. In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo.
Smaill F
Ann Intern Med; 2015 Dec; 163(12):JC5. PubMed ID: 26666807
[No Abstract] [Full Text] [Related]
59. Antiretroviral Therapy in Early HIV Infection.
Corrao S; Prestileo T; Di Lorenzo F
N Engl J Med; 2016 Jan; 374(4):393-4. PubMed ID: 26816021
[No Abstract] [Full Text] [Related]
60. Antiretroviral Therapy in Early HIV Infection.
Lopez-Cortes LF; Gutiérrez-Valencia A; Ben-Marzouk-Hidalgo OJ
N Engl J Med; 2016 Jan; 374(4):393. PubMed ID: 26816020
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
